Want to support and collaborate with ASU’s next generation of biomedical engineers? Have a project or a lingering problem you’d like to solve? Get fresh, innovative perspectives from a team of undergraduate senior students who are dedicated to finding your solution and will work on your proposed project for two full semesters.
Continue reading
Category Archives: AZBio News
Arizona’s Leading Early-Stage Pitch Competition is Back with a Reimagined Format & Editor-in-Chief of Entrepreneur Magazine as Showcase Judge
January 9, 2026 (Tucson, Ariz.) – One of Arizona’s most anticipated entrepreneurial events, IdeaFunding is opening its 2026 competition with a new structure designed to better serve startup founders across the state. A flagship event of TENWEST, IdeaFunding continues to provide early-stage companies with mentorship and pitch training and the opportunity to compete for cash prizes and awards. Applications are now open for businesses across Arizona to join the competition, including a chance to pitch to Jason Feifer, Editor-in-Chief of Entrepreneur Magazine, who will serve as one of the Main Stage Showcase judges.Continue reading
NovaWave Capital Announces Fund Milestone, Launhes Arizona Collaboration on AI Venture Studio
LG NOVA-Supported Fund and Investment Vehicle Welcomes New Investors in NovaWave Fund I Generation to Accelerate AI-First Company Creation in American West and AppalachiaContinue reading
From lab to startup: ASU researchers drive health innovation
Engineering faculty members are taking their inventions to market through entrepreneurial venturesContinue reading
W. L. Gore & Associates to Acquire Conformal Medical, Expanding its Presence in Endovascular Treatments
Acquisition adds next-generation CLAAS® AcuFORM™ Technology to Gore’s portfolio
Picard Medical CEO Patrick NJ Schnegelsberg Elected to AZBio Board of Directors
TUCSON, Ariz., Dec. 30, 2025 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems, LLC, maker of the world’s first total artificial heart approved by both the U.S. Food and Drug Administration (FDA) and Health Canada today announced that Patrick NJ Schnegelsberg, Chief Executive Officer of Picard Medical and SynCardia Systems, LLC, has been elected to the Board of Directors of the Arizona Bioindustry Association (AZBio), the state affiliate in Arizona of the Biotechnology Industry Organization (BIO), the preeminent national association for biotechnology companies His term serving on the board will extend through December 2028.Continue reading
Picard Medical Announces Up to $50 Million Senior Secured Debt Financing
TUCSON, Ariz., Dec. 24, 2025 (GLOBE NEWSWIRE) — Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), parent company of SynCardia Systems LLC, maker of the world’s first total artificial heart approved by both the U.S. FDA and Health Canada, today announced that it has entered into a definitive agreement for a private placement financing of up to $50.0 million aggregate principal amount of senior secured notes due 2028 together with warrants to purchase common stock of the Company. WestPark Capital Inc. served as Sole Placement Agent.Continue reading
Collaboration key to future of ASU Health, President Crow says
Government, health care and academic leaders gather for annual State of the Phoenix Bioscience Core in downtown Phoenix
Aqualung Therapeutics Receives FDA Clearance for Phase 2a Lung Fibrosis Study
Aqualung Therapeutics Receives FDA Clearance for Phase 2a Lung Fibrosis Study
Continue reading